- Poster presentation
- Open Access
Quantitative analysis of post-TAVI aortic regurgitation with cardiovascular magnetic resonance and the relationship to transthoracic echocardiography
© Uddin et al; licensee BioMed Central Ltd. 2013
- Published: 30 January 2013
- Cardiovascular Magnetic Resonance
- Aortic Regurgitation
- Transcatheter Aortic Valve Implantation
- Philips Healthcare
- Severe Aortic Stenosis
Transcatheter Aortic Valve Implantation (TAVI) is increasingly used to treat patients with severe aortic stenosis at high surgical risk. The severity of post-implantation valvular or paravalvular regurgitation has been shown to adversely affect patient outcome. The aim of the study was to assess the prevalence and severity of aortic regurgitation (AR) at 6 months post-TAVI using cardiovascular magnetic resonance (CMR).
Twenty five severe aortic stenosis patients underwent a 1.5T CMR (Intera, Philips Healthcare) scan at baseline and 6 months after CoreValve™ TAVI. LV function was assessed using cine imaging with a steady state free precession pulse sequence. The LV outflow tract was imaged in two planes and through-plane phase contrast velocity imaging was performed perpendicular to the aortic valve and transverse to the aorta at the sinotubular junction. Post-processing was performed using QMass 7.2 and QFlow 5.2 (Medis, Netherlands). AR severity was defined using regurgitant fraction (RF) as: none to mild <8%, mild to moderate 8 to 19%, moderate to severe 20 to 29% and severe >30% .
Transthoracic echocardiography (iE33, Philips Healthcare) was performed at baseline and 6 months follow-up. Aortic regurgitation was graded using a comprehensive integrated approach following the recent Valve Academic Research Consortium (VARC) guidelines.
Mean age was 80.6±6.6yrs, 44% were female, Logistic EuroSCORE 19.5±14.9 LV ejection fraction significantly improved post-TAVI (52.1±11.8% vs. 55.9±9.6%, p<0.0001) and reduction in indexed end-systolic LV volume (46±18 ml/m2 vs. 41±17 ml/m2, p = 0.02). The end-diastolic volume (95±18 ml/m2 vs. 91±20 ml/m2, p = ns) and stroke volume (48±10 ml/m2 vs. 50±10 ml/m2, p = ns) did not change.
Echocardiography showed there was also a statistically significant reductions in peak forward flow velocity (4.87±0.57 ms-1 vs.1.98±0.35 ms-1 p < 0.05), peak pressure gradient (96.1±24.3 mmHg vs.17±5.7 mmHg p < 0.05) and mean pressure gradient (54.8±15.9 mmHg vs.8±3 mmHg p < 0.05) compared to baseline; the effective orifice area (EOA) was significantly larger compared to the baseline state (0.57±0.03 cm2 vs. 1.63±0. 3cm2 p < 0.05).
There was an overall reduction in aortic regurgitant fraction post-TAVI even in the presence of pre-existing AR. CMR can be used in the TAVI population, pre- and post-procedure to quantify the degree of aortic regurgitation
SP is funded by a British Heart Foundation fellowship (FS/10/62/28409).
SP and JPG receive an educational research grant from Philips Healthcare.
- Gabriel RS, Renapurkar R, Bolen MA, Verhaert D, Leiber M, Flamm SD, Griffin BP, Desai MY: Comparison of severity of aortic regurgitation by cardiovascular magnetic resonance versus transthoracic echocardiography. Am J Cardiol. 2011, 108 (7): 1014-20. 10.1016/j.amjcard.2011.05.034.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.